Did You Invest in Société Générale’s 20 Year Callable CMS Spread Notes Series 2012-171 Due December 31, 2032 (CUSIP: 78423EEA8)?
According to Société Générale’s prospectus on CUSIP: 78423EEA8:
The Notes described in this Product Supplement and the Offering Memorandum are not appropriate for all investors, and involve important legal and tax consequences and investment risks, which should be discussed with your professional advisors.
Investors ought to be cautious with this type of investment. According to the Financial Industry Regulatory Authority (FINRA):
If you bought the structured product known as Société Générale’s 20 Year Callable CMS Spread Notes Series 2012-171 Due December 31, 2032 CUSIP: 78423EEA8, and it was sold to you as a safe, liquid, and/or conservative investment, and then you suffered losses, you may have a claim. Contact the attorneys at Sonn Law Group for free consultation.
Image credit: dany13 via Flickr